|Education||BS, Millersville University|
|Current Position||Post Doctoral Fellow|
Kennedy Krieger Institute
Pancreatic cancer is one of the deadliest forms of cancer, with a dismal 5-year survival below 5%. Approximately 10% of cases are thought to have a familial basis, with the majority of those (>80%) having unidentified germline mutations. Recently, our group identified two new pancreatic cancer familial susceptibility genes – PALB2 and ATM. These findings led to the opportunity to identify at-risk individuals and develop targeted therapy. I am interested in identifying additional susceptibility genes in a panel of familial pancreatic cancer cell lines, determining how they contribute to carcinogenesis, and exploiting those genetic defects for more effective therapy options.